scholarly article | Q13442814 |
P50 | author | Adrian Anghel | Q80010846 |
P2093 | author name string | Y Wang | |
Y Liu | |||
L Liu | |||
W Wang | |||
Y Nakagawa | |||
T C Friedman | |||
X Ren | |||
K Lutfy | |||
P2860 | cites work | Targeting proteins to the lumen of endoplasmic reticulum using N-terminal domains of 11beta-hydroxysteroid dehydrogenase and the 50-kDa esterase | Q22009536 |
The glucose-6-phosphatase system | Q24533844 | ||
Obesity and insulin resistance | Q24607078 | ||
Human hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) encoded at 1p36: coding sequence and expression | Q28116645 | ||
The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane | Q28144963 | ||
Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action | Q28204909 | ||
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex | Q28214516 | ||
Does central obesity reflect "Cushing's disease of the omentum"? | Q28236784 | ||
Increased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero | Q28578232 | ||
Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes | Q28582249 | ||
11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function | Q28592552 | ||
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice | Q33782682 | ||
Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. | Q33852573 | ||
Obesity and cortisol | Q34071860 | ||
A transgenic model of visceral obesity and the metabolic syndrome | Q34104691 | ||
Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice | Q34197575 | ||
Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency | Q34213892 | ||
Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity | Q34404014 | ||
Isolation and the complete amino acid sequence of lumenal endoplasmic reticulum glucose-6-phosphate dehydrogenase | Q36348410 | ||
Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1. | Q36796725 | ||
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress | Q36833926 | ||
Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice | Q38354307 | ||
Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. | Q38536054 | ||
Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase | Q40530959 | ||
11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated | Q41036334 | ||
Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids | Q41083075 | ||
The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression | Q41986400 | ||
Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice | Q42022174 | ||
Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus | Q42458833 | ||
Glucocorticoids activate transcription of the gene for the glucose-6-phosphate transporter, deficient in glycogen storage disease type 1b. | Q42510236 | ||
Inhibitory effect of phenolic acids on the proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity | Q42800815 | ||
Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum | Q42811022 | ||
Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes | Q42832571 | ||
Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes | Q43294319 | ||
Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice | Q44219623 | ||
Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. | Q44273298 | ||
11 beta-Hydroxysteroid dehydrogenase activity in hypothalamic obesity | Q44273319 | ||
Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. | Q44794232 | ||
Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum | Q44848212 | ||
Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice | Q45199118 | ||
Adipose tissue 11-beta-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-Phosphate Dehydrogenase gene expressions are increased in patients with type 2 diabetes mellitus | Q46285569 | ||
Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats | Q46442907 | ||
Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation | Q46852972 | ||
Uncoupled redox systems in the lumen of the endoplasmic reticulum. Pyridine nucleotides stay reduced in an oxidative environment | Q46864538 | ||
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice | Q47341892 | ||
Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. | Q51571825 | ||
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. | Q54524505 | ||
11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations | Q61865428 | ||
11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity | Q71038967 | ||
Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity | Q74619299 | ||
The glucose-6-phosphate transporter-hexose-6-phosphate dehydrogenase-11beta-hydroxysteroid dehydrogenase type 1 system of the adipose tissue | Q79782412 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 440-450 | |
P577 | publication date | 2010-11-04 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes | |
P478 | volume | 54 |
Q34800976 | 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue |
Q36179979 | A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding |
Q42540788 | Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress |
Q89455940 | Association of increased renal Cyp24a1 gene expression with low plasma 1,25-dihydroxyvitamin D levels in rats with streptozotocin-induced diabetes |
Q35106896 | Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models |
Q51188763 | Effect of Mifepristone on Corticosteroid Production in Vitro by Adrenal Glands of Rats with Streptozotocin Diabetes. |
Q28541028 | Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats |
Q52641727 | Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity. |
Q37146798 | Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity |
Q48019755 | Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus |
Q36439638 | Involvement of GR and p300 in the induction of H6PD by cortisol in human amnion fibroblasts. |
Q42602503 | Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels |
Q54345628 | Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients. |
Q27302419 | Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity |
Q39220866 | Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice |
Q37629023 | Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice |
Search more.